BOTOX
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Upper Facial Lines
Conditions
Upper Facial Lines
Trial Timeline
Feb 5, 2024 → Dec 17, 2024
NCT ID
NCT06218251About BOTOX
BOTOX is a approved stage product being developed by AbbVie for Upper Facial Lines. The current trial status is completed. This product is registered under clinical trial identifier NCT06218251. Target conditions include Upper Facial Lines.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06218251 | Approved | Completed |
Competing Products
20 competing products in Upper Facial Lines